Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Diabetic Foot Infection

Pegah Kananizadeh1, Solmaz Ohadian Moghadam2, Yasaman Sadeghi1

  • 1Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is common in diabetic foot ulcers (DFUs). SCCmec type IV and V strains are prevalent, highlighting the need for better infection control in diabetic patients.

Area of Science:

  • Infectious Diseases
  • Diabetology
  • Microbiology

Background:

  • Diabetic foot ulcers (DFUs) are a frequent cause of hospitalization for diabetic patients.
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant challenge in DFU treatment.
  • Understanding MRSA epidemiology in DFUs is crucial for effective management.

Purpose of the Study:

  • To determine the SCCmec types of MRSA isolates from diabetic foot ulcers.
  • To investigate the epidemiology of MRSA in diabetic patients with DFUs.
  • To detect virulence toxin genes (pvl and lukED) in MRSA isolates.

Main Methods:

  • Antibiotic susceptibility testing (disk diffusion, E-test) was performed on 145 DFU samples.
  • SCCmec typing was conducted using multiplex PCR.
  • PCR assays were used to detect pvl and lukED virulence genes.

Main Results:

  • MRSA was identified in 19.48% of S. aureus isolates from DFUs.
  • The most common SCCmec types were IV (46.7%), III (30.0%), and V (20.0%).
  • pvl and lukED genes were present in 56.7% and 100% of MRSA isolates, respectively.

Conclusions:

  • High MRSA prevalence in DFUs correlates with extensive antibiotic use in diabetic patients.
  • MRSA isolates exhibited resistance to other critical antibiotics.
  • The dominance of SCCmec types IV and V suggests these clones are entering the clinical setting, even in previously hospitalized patients.